Lyell Immunopharma, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | — | -15,538.7% | -19,692.1% |
| FY2020 | — | -2,732.6% | -2,636.3% |
| FY2021 | — | -2,016.7% | -2,349.5% |
| FY2022 | — | -220.9% | -216.2% |
| FY2023 | — | -190,006.2% | -180,486.2% |
| FY2024 | — | -588,123.0% | -562,285.2% |
| FY2025 | — | -748,344.4% | -762,355.6% |